Kunio Nakane

Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial

Masashi Mizokami, Osamu Yokosuka, Tetsuo Takehara et al. · The Lancet Infectious Diseases · 2015 · 361 citations

Hepatology, Hepatitis C, Viral Hepatitis +8

Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 <scp>HCV</scp> infection: an open‐label, phase 3 trial

Masao Omata, Shuhei Nishiguchi, Yoshiyuki Ueno et al. · Journal of Viral Hepatitis · 2014 · 201 citations · Full text

Japanese Patients, Hcv Infection, Hepatology +13

Westernized Diet is the Most Ubiquitous Environmental Factor in Inflammatory Bowel Disease

Mitsuro Chiba, Kunio Nakane, Masafumi Komatsu · The Permanente Journal · 2019 · 131 citations · Full text

Chronic Inflammatory Diseases, Nutrition, Dysbiosis +17

Relapse Prevention by Plant-Based Diet Incorporated into Induction Therapy for Ulcerative Colitis: A Single-Group Trial

Mitsuro Chiba, Kunio Nakane, Tsuyotoshi Tsuji et al. · The Permanente Journal · 2019 · 54 citations

High Amount of Dietary Fiber Not Harmful But Favorable for Crohn Disease

Mitsuro Chiba, Tsuyotoshi Tsuji, Kunio Nakane et al. · The Permanente Journal · 2015 · 52 citations · Full text

Nutrition, Dietary Fiber Intake, Gut Bacteria +16